Neurodegenerative disease Archives

More News! 18 May 2018

New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech

Spanish biotech Bionure has started an early stage trial of a new drug to treat rare neurologic eye diseases, which also shows promise for treatment of multiple sclerosis and other similar conditions. The therapy (BN201) is the first its class and if successful in clinical trials will be the only treatment that can help repair […]

May 18, 2018 - 2 minutesmins - By Helen Albert

News and Trends 24 Apr 2018

Fundraising Boosts Italian Red Blood Cell Therapy

EryDel has raised €26.5M to develop a red blood cell drug delivery system to treat a rare disease of the immune and nervous systems. Italian biotech EryDel has raised €26.5M to complete a Phase III trial testing a unique technology to treat ataxia telangiectasia, a rare genetic disorder. The fundraising was led by Sofinnova Partners, a leading European venture […]

April 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Mar 2018

Oxford Firm Develops Better Test for ALS Diagnosis

Oxford BioDynamics has presented data from a new diagnostic test that could help not just diagnose ALS but also help patients get a personalized treatment. Amyotrophic lateral sclerosis (ALS) is a motor neuron disease whose diagnosis comes with the hard news that most patients die merely within 3 to 5 years of diagnosis. One of […]

March 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Spanish Research Stem Cell ALS Treatment

News and Trends 19 Mar 2018

Early Research in Bone Marrow Transplants Could Treat ALS

Early stage research from Spain could lead to a treatment for amyotrophic lateral sclerosis (ALS) using adult stem cells from bone marrow to stop progressive muscle paralysis. Researchers from the Neuroscience Institute at the Universidad Miguel Hernández (UMH) in Elche, Alicante, and the Spanish National Research Council (CSIC) aim to test a stem cell treatment for […]

March 19, 2018 - 3 minutesmins - By Alexander Burik

Startup Scout 16 Mar 2018

This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases

Today we’re in Ghent, Belgium, home to several successful biotechs, including Ablynx, to visit ADx Neurosciences. The biotech specializes in biomarker assays for the detection of neurodegenerative diseases. Mission: Founded in 2011, ADx Neurosciences focuses on the development of antibodies to detect biomarkers in the diagnosis of neurodegenerative conditions from Alzheimer’s and Parkinson’s to traumatic brain injury. The anitbodies […]

March 16, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 12 Mar 2018

A Flick of a Switch Can Cause Age-Related Brain Deterioration

Switching certain genes on or off causes the premature aging of stem cells that repair the brain. Identifying them could provide a target for new therapeutic approaches against neurodegenerative diseases. Scientists at the Babraham Insitute in Cambridge and the University of Sapienza in Rome have identified a number of genes involved in the aging of […]

March 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 12 Feb 2018

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

Boehringer Ingelheim has ditched its Alzheimer’s drug after it failed to meet the endpoints of a Phase II trial but will continue to look at it for the treatment of schizophrenia. One of Germany’s biggest pharma companies, Boehringer Ingelheim, has given up on the development of its Alzheimer’s drug, BI 409306, which underwent Phase II testing. The […]

February 12, 2018 - 3 minutesmins - By Alex Dale

cognitive disorders syndesi therapeutics 1

News and Trends 1 Feb 2018

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like Alzheimer’s. Syndesi Therapeutics will use of Belgian biotech UCB’s expertise in drug discovery for neurological conditions to develop new therapies in cognitive disorders using a new […]

February 1, 2018 - 3 minutesmins - By Alex Dale

News and Trends 23 Jan 2018

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

Sobi will enter the clinic after the Investigational New Drug application for its rare metabolic disorder candidate was accepted by the FDA. The Swedish Orphan Biovitrum (Sobi) will begin clinical trials for SOBI003, its candidate for the rare metabolic disorder, Sanfilippo syndrome type A. This was made possible as the FDA’s accepted the company’s Investigational New Drug […]

January 23, 2018 - 2 minutesmins - By Alex Dale

News and Trends 16 Jan 2018

Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s

Researchers have found two proteins that could be used to treat Parkinson’s disease patients by exerting neuroprotective and regenerative effects. Scientists at the University of the Basque Country have found that two neurotrophic factors work in synergy to benefit patients with early-stage Parkinson’s disease. The findings, based on research carried out across a number of studies, […]

January 16, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Having developed multispecific antibodies with F-star, Denali Therapeutics has joined forces with Takeda Pharmaceuticals to commercialize Alzheimer’s drugs using the technology. F-star’s bispecific antibody technology has received validation in the form of two pharma companies using it for the development of new drugs for neurodegenerative diseases. San Francisco-based Denali Therapeutics and Japanese company Takeda will collaborate on […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 8 Jan 2018

And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial

Minoryx Therapeutics has dosed the first patient in its Phase II/III trial for patients with adrenomyeloneuropathy, a condition that affects 1 in 17,000 newborns worldwide. Minoryx Therapeutics focuses on the development of new drugs for orphan diseases like adrenomyeloneuropathy. The first two patients in ADVANCE, a Phase II/III clinical trial of MIN-102, have started their treatment. The trial, […]

January 8, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Neurodegenerative disease

New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech

Fundraising Boosts Italian Red Blood Cell Therapy

Oxford Firm Develops Better Test for ALS Diagnosis

Early Research in Bone Marrow Transplants Could Treat ALS

This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases

A Flick of a Switch Can Cause Age-Related Brain Deterioration

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!